Migraine with aura study using CGRP to trigger attacks
Part of Brain & nervous system clinical trials.
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had migraines with aura for at least 12 months, with at least 1 aura day per month on average over the last 3 months.
- You do not have heart or blood vessel disease, or untreated high or low blood pressure.
- You have not taken any migraine rescue medications (like triptans or painkillers) in the 48 hours before the infusion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
This study tests whether giving a substance called PACAP38 can trigger a migraine with aura in a controlled setting. It helps understand the causes of migraines and may lead to better treatments.
This study measures a substance called CGRP in saliva from people with migraine and healthy volunteers to see how it changes with age and sex. It may help researchers understand migraine better.
This study tests whether amiloride can reduce how often migraine aura happens. It’s a proof-of-concept early study, meaning the main goal is to see if the approach seems to work and is safe for people with frequent aura.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This study looks at whether a natural substance called amylin can trigger migraine attacks in people who get migraines without aura. If you join, you'll receive an infusion and be monitored to see if you get a migraine, which could help researchers understand migraine causes.
Hear when a new Migraine With Aura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.